Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/7/15  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Timothy J. Triche

Wrong Dr. Timothy J. Triche?

Director of the Center for Person...

Phone: (323) ***-****  
Email: t***@***.edu
Childrens Hospital Los Angeles
4650 Sunset Blvd. MS#75
Los Angeles , California 90027
United States

Company Description: About Childrens Hospital Los Angeles ( Founded in 1901, Childrens Hospital Los Angeles has been treating the most seriously ill and...   more

Employment History

Board Memberships and Affiliations


  • MD
  • PhD
    Tulane University
  • BSc , Physics
    Cornell University
  • PhD
    Tulane Univeristy
  • MD PhD Chief Medical Officer
  • MD/PhD
    University of Southern California
161 Total References
Web References
Pediatric Bioscience Management, 7 Oct 2015 [cached]
Timothy J. Triche, M.D., Ph.D. Medical Director of Laboratory Services Dr. Triche is a board-certified anatomical and molecular pathologist and academic professor of pathology and laboratory medicine. Tim has built, operated and owned high-complexity molecular diagnostics testing laboratories for the past 30 years and runs the PBI clinical laboratory. Currently, Dr. Triche is the co-director of the Center for Personalized Medicine, and Chairman Emeritus Dept. of Pathology and Laboratory Medicine, at Children's Hospital Los Angeles. Previously, he was the director of Specialized Diagnostics and Section Chief for the Laboratory of Pathology at the National Cancer Institute before becoming Pathologist-in-Chief at Children's Hospital of Los Angeles and Vice-Chair for the Department of Pathology at the Keck School of Medicine at the University of Southern California. He is a founding member of the Association for Molecular Pathology and has previously served as a senior executive in a number of medical companies, including founder and CEO of Oncomed Inc. Dr. Triche received his BSc in Physics at Cornell University, MD and PhD at Tulane University and completed his residency in anatomical pathology at Washington University School of Medicine. Tim's research in the field of applied genomics and molecular biology has been recognized by numerous awards, grants and over 200 peer-reviewed publications.
Scientific Advisory Board | Wafergen, 31 Aug 2015 [cached]
Timothy J. Triche, M.D., Ph.D.
As Director of the Center for Personalized Medicine at Children's Hospital Los Angeles, Dr. Triche manages a large cancer genomics, biology, and nanotechnology laboratory research program funded by grants from the National Cancer Institute (NCI), Department of Defense (DOD), Department of Energy (DOE), Children's Oncology Group (COG), University of Southern California (USC) Norris Comprehensive Cancer Center, and several private philanthropic entities. Until recently, Dr. Triche was Chief of the Department of Pathology and Laboratory Medicine for over 20 years. Previously, Dr. Triche was Section Chief and Head of Molecular Diagnostics in the Laboratory of Pathology at the National Cancer Institute. He received his pathology specialty training at Washington University School of Medicine in St. Louis and subsequently did a fellowship at the NCI prior to joining the faculty there. Dr. Triche received his undergraduate degree in physics and biology from Cornell University, where he was a Cornell National Scholar, and M.D. and Ph.D. degrees from Tulane University, where he was a Medical Scientist Training Program grant recipient.
Dr. Triche is a Beckman Fellow of the Beckman Macular Research Center at the Doheny Eye Institute, and serves on the Board of Directors of publicly traded LTC Properties Corporation and several small private biotech companies. He is also on the board of PROOF, a Vancouver, Canada-based centre for personalized medicine related to organ transplantation. He is a founding member of Children's Oncology Group, where he has served in multiple capacities, including Associate Chair for Translational Research. He is a standing member of NCI's Advisory Committees for clinical and basic cancer biology studies, where he frequently reviews grant proposals in cancer biology and treatment, genomics, and nanotechnology.
To us, the word 'actionable means ..., 15 Jan 2013 [cached]
To us, the word 'actionable means finding a precise diagnosis for a case; reducing risk for family members; and predicting if treatments will be effective or futile," said Tim Triche, M.D., Ph.D., a clinician with 30 years of scientific and medical experience at pioneering companies including OncorMed, Genelogic, and GenomeDx and also Chairman of Pathology at Children's Hospital of Los Angeles, who serves on the company's Board of Directors.
"This is the new wave of genomics medicine; one that we expect to set new precedents and have a major impact on healthcare overall," said Dr. Triche. SV Bio is currently providing diagnostic testing services to physicians and centers of excellence for all heritable genetic conditions.
SV Bio's Board of Directors includes Timothy Triche, M.D., Ph.D., of the Center for Personalized Medicine, Children's Hospital Los Angeles; Warren Hogarth, Ph.D., M.B.A., a partner at Sequoia Capital; Todd Cozzens, M.B.A., formerly of Picis, who serves as SV Bio's Chairman; and Jeremy Friese, M.D., M.B.A., who leads business development for Mayo Clinic's Center for Individualized and practices medicine at Mayo Clinic.
Team, 18 Dec 2014 [cached]
Tim Triche, M.D., Ph.D. - Chairman & Founder Dr. Triche is a seasoned executive who also has over 25 years of experience in cancer diagnosis and patient treatment. He is currently the Chief Pathologist at the Childrens Hospital Los Angeles and Vice Chairman of the Department of Pathology, USC School of Medicine. Tim is a recognized expert in the analysis and use of cancer targets and pathways. He has served as a senior executive, in a number of medical companies, including Chairman and CEO of Oncormed.
Timothy Triche MD, ..., 18 Oct 2015 [cached]
Timothy Triche MD, PhD
Chief Medical Officer
Dr. Triche is co-founder of NanoValent and is board certified in pathology and is on the staff of Children's Hospital Los Angeles and a faculty at the University of Southern California. His expertise centers on the field of tumor cell biology. Dr. Triche has been a principle and founder in several publicly traded companies that have raised a total of $70M in public markets. He was co-founder of OncorMed, which was sold to Gene Logic (GLGC).
Other People with the name "Triche":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.